Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker

Abstract RNA‐binding Motif Protein39 (RBM39) is identified as a splicing factor and transcription coactivator. Despite mounting evidence that RBM39 plays…